Air India pilots drug test: Airline expands screening beyond DGCA norms
Synopsis
Key Takeaways
Air India on Tuesday, 18 August confirmed it has voluntarily launched a comprehensive pilot testing programme that goes beyond existing regulatory requirements set by aviation authorities, reaffirming what the Tata-owned carrier described as its 'unwavering commitment to safety and professionalism.' The move comes amid reports that at least two more pilots have failed preliminary drug tests as part of an expanded screening drive triggered by an in-flight incident.
What Air India Said
In an official statement, the airline said the testing process is currently underway and called on media and stakeholders to hold back from speculation. Air India stated: 'As the process is ongoing, we urge media and other stakeholders to refrain from speculation or reporting based on unverified or unsubstantiated information.' The carrier added that 'any assessment should await the completion of the process and verified facts.'
What Triggered the Expanded Screening
The expanded programme was ordered after the pilot-in-command of a Phuket-New Delhi flight allegedly failed two urine tests following the aircraft's landing. Marijuana was reportedly detected in his system. In response, Air India introduced a new standard operating procedure (SOP) mandating drug testing for all its pilots — a scope that goes well beyond what the Directorate General of Civil Aviation (DGCA) currently requires.
Two More Pilots Fail Preliminary Tests
According to reports citing sources, two additional Air India pilots have failed preliminary drug screenings conducted under the expanded programme. Both pilots have been de-rostered pending confirmation of final results. Final drug test results typically take between 24 and 48 hours to process, meaning the full picture is still emerging. More than 300 pilots have reportedly undergone the testing process so far.
Broader Implications for Aviation Safety
The episode marks one of the most significant internal safety audits by an Indian carrier in recent memory. Notably, Air India is acting proactively rather than waiting for regulatory compulsion — a posture that industry observers say reflects the reputational pressure the airline faces as it undergoes a major post-acquisition overhaul under the Tata Group. This is not the first time Indian aviation has confronted crew substance concerns, but the scale of the voluntary sweep — covering the entire pilot roster — is unprecedented for a domestic carrier. How the results unfold will likely shape DGCA policy on mandatory screening norms going forward.